As of June 2025, MDT's current EPS stands at $3.31, according to the latest financial reports. For the year 2024, the company recorded an earnings per share (EPS) of $2.77, which marks a drop compared to its EPS of $2.83 in 2023. MDT reported an EPS of $1.01 for the quarterly report ending on Jan 24, 2025.
For 2024, Medtronic's EPS was $2.77, a drop of 2.1% from $2.83 in 2023. For the fiscal quarter that ended on Jan 24, 2025, the per-share earnings was $1.01, showing a 2% increase from the same quarter last year. For the twelve months ending January 2025, the EPS is $3.31. For the year 2023, the yearly earnings per share was $2.83, marking a decrease of 24.5% from 2022.
Medtronic has registered an increase in EPS of 2% during the last 12 months (YoY, quarterly). In the last three years, MDT recorded an average annual EPS growth rate of 1.1%. Medtronic had an average annual EPS growth rate of -4.2% during the last 5 years. Across the last decade, MDT had an average annual EPS growth of -1%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
EW Edwards Lifesciences Corp | 11.07 | 202.2% | 42.5% | 33% |
CNMD CONMED Corp | 14.73 | 104.3% | 26.1% | 33.5% |
JNJ Johnson & Johnson | 16.91 | -57.9% | -9.7% | 0.4% |
ABT Abbott Laboratories | 17.22 | 133.8% | 24.5% | 29.9% |
MDT Medtronic plc | 25.86 | -2.1% | 1.1% | -4.2% |
SYK Stryker Corp | 51.01 | -5.8% | 14.1% | 7.1% |
BSX Boston Scientific Corp | 74.22 | 16.7% | 22.2% | -17.9% |
BAX Baxter International Inc | N/A | -124.2% | N/A | N/A |
OMI Owens & Minor Inc | N/A | -775.9% | N/A | N/A |
IART Integra Lifesciences Holdings Corp | N/A | -110.6% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.